Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy

Cancer Research

Volumn 59, Issue 20, 1999, Pages 5245-5249

  Mukai, Shigehiko ^a   Kjærgaard, Jørgen ^a   Shu, Suyu ^a   Plautz, Gregory E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; MONOCLONAL ANTIBODY CD3; PERTUSSIS TOXIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; FIBROSARCOMA; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR REGRESSION;

ANIMALS; CELL MOVEMENT; FEMALE; IMMUNOTHERAPY, ADOPTIVE; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; PERTUSSIS TOXIN; T-LYMPHOCYTES; VIRULENCE FACTORS, BORDETELLA;

EID: 0032698212     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shu, S., Chou, T., and Rosenberg, S. A. In Vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice. Cancer Res., 47: 1354-1360, 1987.
2. Yoshizawa, H., Chang, A. E., and Shu, S. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. J. Immunol., 147: 729-737, 1991.
3. Shu, S., Krinock, R. A., Matsumura, T., Sussman, J. J., Fox, B. A., Chang, A. E., and Terman, D. S. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells. J. Immunol., 152: 1277-1288, 1994.
4. Peng, L., Shu, S., and Krauss, J. C. Treatment of subcutaneous tumor with adoptively transferred T cells. Cell. Immunol., 178: 24-32, 1997.
5. Inoue, M., Plautz, G. E., and Shu, S. Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells. Cancer Res., 56: 4702-4708, 1996.
6. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76: 301-314, 1994.
7. Butcher, E. C., and Picker, L. J. Lymphocyte homing and homeostasis. Science (Washington DC), 272: 60-66, 1996.
8. Roth, S. J., Carr, M. W., and Springer, T. A. C-C chemokines, but not the C-X-C chemokines interleukin-8 and interferon-γ inducible protein-10, stimulate transendothelial chemotaxis of T lymphocytes. Eur. J. Immunol., 25: 3482-3488, 1995.
9. Sallusto, F., Lanzavecchia, A., and Mackay, C. R. Chemokines and chemokine receptors in T-cell priming and TH1/Th2-mediated responses. Immunol. Today, 19: 568-574, 1998.
10. Wang, D. M., Deng, X., Gong, W., and Su, S. Chemokines and their role in tumor growth and metastasis. J. Immunol. Methods, 220: 1-17, 1998.
11. Katada, T., and Ur, M. The A protomer of islet-activating protein, pertussis toxin, as an active peptide catalyzing ADP-ribosylation of a membrane protein. Arch. Biochem. Biophys., 224: 290-298, 1983.
12. Gilman, A. G. G proteins and regulation of adenylyl cyclase. J. Am. Med. Assoc., 262: 1819-1825, 1989.
13. Kuang, Y., Wu, Y., Jiang, H., and Wu, D. Selective G protein coupling by C-C chemokine receptors. J. Biol. Chem., 277: 3975-3978, 1996.
14. Spangrude, G. J., Braaten, B. A., and Daynes, R. A. Molecular mechanisms of lymphocyte extravasation. I. Studies of two selective inhibitors of lympocyte recirculation. J. Immunol., 132: 354-362, 1984.
15. Spangrude, G. J., Sacchi, F., Hill, H. R., Van Epps, D. E., and Daynes, R. A. Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J. Immunol., 135: 4135-4143, 1985.
16. Bargatze, R. F., and Butcher, E. C. Rapid G protein-regulated activation event involved in lymphocyte binding to high endothelial venules. J. Exp. Med., 178: 367-372, 1993.
17. Cyster, J. G., and Goodnow, C. C. Pertussis toxin inhibits migration of B and T lymphocytes into splenic white pulp cords. J. Exp. Med., 182: 581-586, 1995.
18. Barth, R. J., Jr., Bock, S. N., Mule, J. J., and Rosenberg, S. A. Unique murine tumor-associated antigens identified by tumor infiltrating lymphocytes. J. Immunol., 144: 1531-1537, 1990.
19. Mukai, S., Kagamu, H., Shu, S., and Plautz, G. E. Critical role of CD11a (LFA-1) in therapeutic efficacy of systemically transferred antitumor effector T cells. Cell. Immunol., 192: 122-132, 1999.
20. Kjærgaard, J., and Shu, S. Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression. J. Immunol., 163: 751-759, 1999.
21. low cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes. J. Immunol., 160: 3444-3452, 1998.
22. Plautz, G. E., Touhalisky, J. E., and Shu, S. Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells. Cell. Immunol., 178: 101-107, 1997.
23. Siveke, J. T., and Hamman, A. T helper 1 and T helper 2 cells respond differently to chemokines. J. Immunol., 160: 550-554, 1998.
24. Loetscher, P., Uguccioni, M., Bordoli, L., Baggolini, M., Moser, B., Chizzolini, C., and Dayer, J. M. CCR5 is characteristic of Th1 lymphocytes. Nature (Lond.), 391: 344-345, 1998.
25. Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., and Mackay, C. R. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest., 101: 746-754, 1998.
26. Gray, L. S., Huber, K. S., Gray, M. C., Hewlett, E. L., and Engelhard, V. H. Pertussis toxin effects on T lymphocytes are mediated through CD3 and not by pertussis toxin catalyzed modification of a G protein. J. Immunol., 142: 1631-1638, 1989.
27. Modesto, J., Breittmayer, J. P., Greiner-Brossette, N., Fehlmann, M., and Cousin, J. L. Pertussis toxin-sensitive G-proteins are not involved in activation of T-lymphocytes. Cell Signalling, 3: 25-33, 1991.